Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Cronos Group Inc. (CRON) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Cronos Group Reports 2023 Second Quarter Results Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million"
05/09/2023 8-K Quarterly results
Docs: "Exhibit 99.1 Cronos Group Reports 2023 First Quarter Results Industry-leading"
11/07/2022 8-K Quarterly results
Docs: "Cronos Group Reports 2022 Third Quarter Results Reported"
08/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
02/18/2022 8-K Quarterly results
Docs: "Cronos Group Reports 2021 Third Quarter Results Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements Announces strategic realignment to support future growth strategies"
08/06/2021 8-K Quarterly results
Docs: "Cronos Group Reports 2021 Second Quarter Results Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company"
05/07/2021 8-K Quarterly results
02/26/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Cronos Group Reports 2020 Third Quarter Results Kurt Schmidt appointed President and CEO&#59; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD brand, Happy Dance™, in the U.S. market in partnership with Kristen Bell"
08/06/2020 8-K Quarterly results
05/08/2020 8-K Quarterly results
Docs: "Cronos Group Reports 2020 First Quarter Results"
03/30/2020 8-K Quarterly results
Docs: "Cronos Group Reports 2019 Fourth Quarter and Full-Year Results Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids in partnership with Ginkgo Bioworks Enhanced research and development capabilities at the Peace Naturals Campus Advanced operational readiness of Cronos Israel with GAP and GMP certifications",
"Unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019",
"Unaudited condensed interim consolidated financial statements for the three and six months ended June 30, 2019",
"Unaudited condensed interim consolidated financial statements for the three and nine months ended September 30, 2019"
11/12/2019 6-K Quarterly results
05/09/2019 6-K Quarterly results
Docs: "FORM 6-K",
"Cronos Group Inc. Announces First Quarter 2019 Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy